Cerus Corporation stock is up 22.65% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.43% of the previous 27 March’s closed higher than February.
Cerus Corporation focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America and internationally.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!